Possible new target for sickle cell disease and beta thalassemia treatment identified

Harvard Medical School researchers astatine Boston Children's Hospital and Dana-Farber Cancer Institute person identified a caller pathway that regulates the accumulation of fetal hemoglobin, a signifier of hemoglobin that usually gets replaced soon aft commencement by big hemoglobin.